These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33663130)

  • 21. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
    Stellbaum C; Ayral Y; Morguet A; Schultheiss HP; Rauch U
    Cardiovasc Revasc Med; 2012; 13(3):159-66. PubMed ID: 22503564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of aspirin resistance in Asian-Indian patients with stable coronary artery disease.
    Chadha DS; Sumana B; Karthikeyan G; Jayaprasad V; Arun SS
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):E126-E131. PubMed ID: 24482126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Daffara V; Pergolini P; Rolla R; Marino P; Bellomo G; Carriero A; De Luca G;
    Vascul Pharmacol; 2017 Aug; 93-95():42-47. PubMed ID: 28433569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of platelet function during exercise in normal subjects and coronary artery disease patients: Potential role of platelet activation in myocardial ischemia.
    Mehta J; Mehta P
    Am Heart J; 1982 Jan; 103(1):49-53. PubMed ID: 6172974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls.
    Wallén NH; Held C; Rehnqvist N; Hjemdahl P
    Eur Heart J; 1997 May; 18(5):807-15. PubMed ID: 9152651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy.
    Petricevic M; Biocina B; Konosic S; Kopjar T; Kunac N; Gasparovic H
    Heart Vessels; 2013 Jan; 28(1):57-65. PubMed ID: 22203409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial.
    Zheng YY; Wu TT; Yang Y; Hou XG; Gao Y; Chen Y; Yang YN; Li XM; Ma X; Ma YT; Xie X
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):211-221. PubMed ID: 31603191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial studies of platelet factor 4 and beta thromboglobulin during exercise in patients with coronary artery disease.
    Strauss WE; Cella G; Parisi AF; Sasahara AA
    Am Heart J; 1985 Aug; 110(2):293-9. PubMed ID: 2411121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Platelets; 2015; 26(6):545-51. PubMed ID: 25167467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin in coronary artery disease: an appraisal of functions and limitations.
    Würtz M
    Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
    Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
    Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study.
    Waehre T; Damås JK; Pedersen TM; Gullestad L; Yndestad A; Andreassen AK; Frøland SS; Semb AG; Hansteen V; Gjertsen E; Ueland T; Brosstad F; Solum NO; Aukrust P
    J Thromb Haemost; 2006 Oct; 4(10):2140-7. PubMed ID: 16856976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of mean platelet aggregation degree on long-term clinical outcomes among patients undergoing a complex percutaneous coronary intervention.
    Li Q; Li M; Yu X; He J; Gao Y; Zhang X; Wu C; Luo Y; Zhang Y; Ren X
    Coron Artery Dis; 2017 Sep; 28(6):478-485. PubMed ID: 28562382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel improves microvascular endothelial function in subjects with stable coronary artery disease.
    Willoughby SR; Luu LJ; Cameron JD; Nelson AJ; Schultz CD; Worthley SG; Worthley MI
    Heart Lung Circ; 2014 Jun; 23(6):534-41. PubMed ID: 24529502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease.
    Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Würtz M; Grove EL; Hvas AM; Jensen HK; Kristensen SD
    Int J Cardiol; 2019 Jul; 286():152-158. PubMed ID: 30837090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease.
    Pamukcu B; Oflaz H; Onur I; Midilli K; Yilmaz G; Yilmaz E; Nisanci Y
    Circ J; 2008 Jan; 72(1):61-6. PubMed ID: 18159101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.